These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 8687113
1. Involvement of intracellular glutathione in induction of apoptosis by cisplatin in a human pharyngeal carcinoma cell line. Sugimoto C, Matsukawa S, Fujieda S, Noda I, Tanaka N, Tsuzuki H, Saito H. Anticancer Res; 1996; 16(2):675-80. PubMed ID: 8687113 [Abstract] [Full Text] [Related]
2. Relationship between cellular glutathione level and susceptibility to LAK killing in human pharyngeal carcinoma cell line. Noda I, Fujieda S, Saito H, Tanaka N, Sugimoto C, Hoshino T, Yagita M. Anticancer Res; 1994; 14(3A):1117-20. PubMed ID: 8074461 [Abstract] [Full Text] [Related]
3. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Russo A, DeGraff W, Friedman N, Mitchell JB. Cancer Res; 1986 Jun; 46(6):2845-8. PubMed ID: 2421885 [Abstract] [Full Text] [Related]
4. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, de Vries EG. Cancer Res; 1992 Dec 15; 52(24):6885-9. PubMed ID: 1458477 [Abstract] [Full Text] [Related]
5. Glutathione depletion restores the susceptibility of cisplatin-resistant chronic myelogenous leukemia cell lines to Natural Killer cell-mediated cell death via necrosis rather than apoptosis. Dedoussis GV, Andrikopoulos NK. Eur J Cell Biol; 2001 Sep 15; 80(9):608-14. PubMed ID: 11675936 [Abstract] [Full Text] [Related]
6. The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin. Lu Y, Cederbaum A. Free Radic Biol Med; 2007 Oct 01; 43(7):1061-75. PubMed ID: 17761302 [Abstract] [Full Text] [Related]
7. In vivo selective modulation of tissue glutathione in a rat mammary carcinoma model. Baruchel S, Wang T, Farah R, Jamali M, Batist G. Biochem Pharmacol; 1995 Oct 26; 50(9):1505-8. PubMed ID: 7503802 [Abstract] [Full Text] [Related]
8. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG. Br J Cancer; 1990 Jul 26; 62(1):72-7. PubMed ID: 2390486 [Abstract] [Full Text] [Related]
9. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line]. Bier H. Laryngorhinootologie; 1990 Jan 26; 69(1):16-20. PubMed ID: 2310456 [Abstract] [Full Text] [Related]
10. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells. Lai SL, Hwang J, Perng RP, Whang-Peng J. Oncol Res; 1995 Jan 26; 7(1):31-8. PubMed ID: 7549042 [Abstract] [Full Text] [Related]
11. [Potentiation of cisplatin sensitivity of cisplatin-resistant human ovarian cancer cell lines by L-buthionine-S,R-sulfoximine]. Kudoh K, Kita T, Hirata J, Ishii K, Hiramatsu H, Kikuchi Y, Nagata I. Nihon Sanka Fujinka Gakkai Zasshi; 1994 Jun 26; 46(6):525-32. PubMed ID: 8040625 [Abstract] [Full Text] [Related]
12. Circumvention of drug resistance in cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79 in vitro and in vivo. Bier H. Acta Otolaryngol; 1991 Jun 26; 111(4):797-806. PubMed ID: 1950544 [Abstract] [Full Text] [Related]
13. Protective role of intracellular glutathione against oxidized low density lipoprotein in cultured endothelial cells. Kuzuya M, Naito M, Funaki C, Hayashi T, Asai K, Kuzuya F. Biochem Biophys Res Commun; 1989 Sep 29; 163(3):1466-72. PubMed ID: 2783144 [Abstract] [Full Text] [Related]
14. Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. The role of intracellular oxidation. Troyano A, Fernández C, Sancho P, de Blas E, Aller P. J Biol Chem; 2001 Dec 14; 276(50):47107-15. PubMed ID: 11602574 [Abstract] [Full Text] [Related]
15. Enhancement of intracellular glutathione promotes lymphocyte activation by mitogen. Fidelus RK, Tsan MF. Cell Immunol; 1986 Jan 14; 97(1):155-63. PubMed ID: 3742607 [Abstract] [Full Text] [Related]
16. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells. Oguchi H, Kikkawa F, Kojima M, Maeda O, Mizuno K, Suganuma N, Kawai M, Tomoda Y. Anticancer Res; 1994 Jan 14; 14(1A):193-200. PubMed ID: 7909418 [Abstract] [Full Text] [Related]
17. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells. Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E. Mol Pharmacol; 1996 Jun 14; 49(6):1012-20. PubMed ID: 8649339 [Abstract] [Full Text] [Related]
18. Relationship between intracellular glutathione level and the mode of cell death induced by pingyangmycin. Tai KW, Lii CK, Chou MY, Chang YC. Oral Oncol; 2003 Jan 14; 39(1):13-8. PubMed ID: 12457716 [Abstract] [Full Text] [Related]
19. Effect of glutathione depletion on the cytotoxicity of cisplatin and iproplatin in a human melanoma cell line. Pendyala L, Perez R, Weinstein A, Zdanowicz J, Creaven PJ. Cancer Chemother Pharmacol; 1997 Jan 14; 40(1):38-44. PubMed ID: 9137527 [Abstract] [Full Text] [Related]
20. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines. Peters RH, Jollow DJ, Stuart RK. Cancer Res; 1991 May 15; 51(10):2536-41. PubMed ID: 2021933 [Abstract] [Full Text] [Related] Page: [Next] [New Search]